DF
Drug FarmDrug Farm is a biotech developing AI-designed small-molecule drugs for rare and immune-inflammatory diseases, led by DF-003, a Phase 3 ALPK1 inhibitor for ROSAH syndrome.
2 Pulse stories
OB
Ollin BiosciencesClinical-stage biopharmaceutical company developing best-in-disease therapies for vision-threatening eye diseases, including a VEGF/Ang2 bispecific antibody in Phase 3 for DME and wet AMD.
2 Pulse stories
Total Raised
$138M
$430M
Drug FarmOllin Biosciences
Last ValuationNot disclosed
Biotech
Sector
Biotech
2015
Founded
2023
Shanghai, China / New York, NY
HQ
Chicago, Illinois
Private
Status
Private
Drug Farm investors
Shanghai Pudong Leading Area Investment CenterShanghai Puxing Collaborative Private Equity FundDetong CapitalWuXi AppTecBioVeda China FundYD CapitalBetta CapitalWedo Venture Management
Ollin Biosciences investors
ARCH Venture PartnersTCGX (TCG Crossover)Andreessen HorowitzMubadala CapitalMonograph CapitalBlackstone Multi-Asset InvestingCommodore CapitalRA Capital Management
Data from Value Add Pulse coverage and company research — see the full threads for Drug Farm and Ollin Biosciences.